- Home
- DAC vs NVCR Comparison
DAC vs NVCR Comparison
Compare DAC & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DAC
- NVCR
- Stock Information
- Founded
- DAC 1972
- NVCR 2000
- Country
- DAC Greece
- NVCR Switzerland
- Employees
- DAC N/A
- NVCR N/A
- Industry
- DAC Marine Transportation
- NVCR Medical/Dental Instruments
- Sector
- DAC Consumer Discretionary
- NVCR Health Care
- Exchange
- DAC Nasdaq
- NVCR Nasdaq
- Market Cap
- DAC 1.6B
- NVCR 1.9B
- IPO Year
- DAC 2006
- NVCR 2015
- Fundamental
- Price
- DAC $88.54
- NVCR $17.02
- Analyst Decision
- DAC Strong Buy
- NVCR Buy
- Analyst Count
- DAC 1
- NVCR 7
- Target Price
- DAC $105.00
- NVCR $32.43
- AVG Volume (30 Days)
- DAC 100.2K
- NVCR 1.2M
- Earning Date
- DAC 08-04-2025
- NVCR 07-24-2025
- Dividend Yield
- DAC 3.85%
- NVCR N/A
- EPS Growth
- DAC N/A
- NVCR N/A
- EPS
- DAC 24.48
- NVCR N/A
- Revenue
- DAC $1,013,968,000.00
- NVCR $621,711,000.00
- Revenue This Year
- DAC $2.55
- NVCR $5.44
- Revenue Next Year
- DAC N/A
- NVCR $9.05
- P/E Ratio
- DAC $3.65
- NVCR N/A
- Revenue Growth
- DAC 3.10
- NVCR 18.27
- 52 Week Low
- DAC $65.40
- NVCR $14.17
- 52 Week High
- DAC $90.95
- NVCR $34.13
- Technical
- Relative Strength Index (RSI)
- DAC 58.24
- NVCR 47.92
- Support Level
- DAC $88.49
- NVCR $17.33
- Resistance Level
- DAC $90.40
- NVCR $18.59
- Average True Range (ATR)
- DAC 1.90
- NVCR 0.69
- MACD
- DAC 0.13
- NVCR 0.01
- Stochastic Oscillator
- DAC 71.33
- NVCR 31.44
About DAC Danaos Corporation
Danaos Corp is an international owner of containerships. It provides international seaborne transportation services by operating vessels in the containership sector of the shipping industry. The company's customers include, HMM, MSC, Yang Ming, Hapag Lloyd, ZIM, Maersk, COSCO, OOCL, ONE, PIL, Sealead, Niledutch, Samudera, OSC, and Arkas. Geographically, the company operates in Australia-Asia, Europe, and America, with maximum revenue from the Australia-Asia region. It has two reporting segments Container vessels and Drybulk vessels segment. It generates the majority of its revenue from Container vessels.
About NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.